Views

Abstract: 6376

PDF (Russian): 1968

Cited-by

1. Fomina DS, Salogub GN, Maslyanskiy AL, Gridneva GI, Ptushkin VV, Sitnikova MY, et al. Safety of sipavibart as a pre-exposure prophylaxis for COVID-19 in individuals at high risk of developing severe disease: results of the NOVELLA clinical study conducted in the Russian population. Terapevticheskii arkhiv. 2024;96(12):1127. doi: 10.26442/00403660.2024.12.203103
2. Karasev AA, Poteshkina NG, Lysenko MA, Krylova NS, Svanadze AM, Maslova MY, et al. Right heart status in patients with COVID-19: a literature review. Russian Medicine. 2024;30(3):260. doi: 10.17816/medjrf629975
3. Krinochkin DV, Yaroslavskaya EI, Shirokov NE, Gorbatenko EA, Gultyaeva EP, Krinochkina IR, et al. Prevalence of cardiovascular pathology and relationship of left ventricular global longitudinal strain three months after COVID-19. Clinical Medicine (Russian Journal). 2023;101(2-3):123. doi: 10.30629/0023-2149-2023-101-2-3-123-130
4. Ageev AA, Kozhevnikova MV, Emelyanov AV, Krivova AV, Shumskaya YF, Musaeva LM, et al. The Effect of COVID-19 on Long-Term Cardiac Function in Patients With Chronic Heart Failure. Kardiologiia. 2022;62(12):23. doi: 10.18087/cardio.2022.12.n2265
5. Kutishenko NP, Lukyanov MM, Martsevich SY, Pulin AA, Andreenko EY, Voronina VP, et al. Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19. Cardiovascular Therapy and Prevention. 2023;21(12):3467. doi: 10.15829/1728-8800-2022-3467
6. Shchepikhin EI, Shmelev EI, Ergeshov AE. Pulmonary fibrosis after a new coronavirus infection – versions and controversies: A review. Terapevticheskii arkhiv. 2024;96(3):298. doi: 10.26442/00403660.2024.03.202632
7. Gubareva EY, Fatenkov OV, Konstantinov DY, Gubareva IV. Clinical and anamnestic analysis of in-patients with COVID-19 infection hospitalized during one month. Science and Innovations in Medicine. 2022;7(4):226. doi: 10.35693/2500-1388-2022-7-4-226-231
8. Bashkinov RA, Batluk TI, Melnikov ES, Trubnikova MA, Arutyunov AG. Influence of metabolic disorders on the development of renal pathology. South Russian Journal of Therapeutic Practice. 2022;3(2):7. doi: 10.21886/2712-8156-2022-3-2-7-18
9. Salukhov VV, Arutyunov GP, Tarlovskaya EI, Batluk TI, Bashkinov RA, Samus IV, et al. The impact of carbohydrate metabolism disorders on the early and long-term clinical outcomes of patients with COVID-19 according to the AKTIV and AKTIV 2 registries. Problems of Endocrinology. 2023;69(1):36. doi: 10.14341/probl13175
10. Vikulova OÐ, Zheleznyakova AV, Serkov AA, Isakov MA, Vagapova GR, Valeeva FV, et al. Multiplex analysis of post-Covid cardiorenal complications in patients with type 1 and type 2 diabetes mellitus according to the mobile diagnostic and treatment center (Diamobil). Problems of Endocrinology. 2024;70(4):65. doi: 10.14341/probl13426
11. Lukyanov MM, Andreenko EY, Martsevich SY, Kutishenko NP, Voronina VP, Dindikova VA, et al. Two-year outcomes in patients after hospitalization for COVID-19: data from the TARGET-VIP registry. Cardiovascular Therapy and Prevention. 2023;22(10):3757. doi: 10.15829/1728-8800-2023-3757
12. Arutyunov A, Tarlovskaya EI, Galstyan GR, Batluk TI, Bashkinov RA, Arutyunov GP, et al. The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries. Problems of Endocrinology. 2023;68(6):89. doi: 10.14341/probl13165
13. Obukhova IA, Demko IV, Petrova MM, Bochkareva VO, Kozlov EV. Clinical course and consequences of coronavirus infection in patients with arterial hypertension. Bulletin Physiology and Pathology of Respiration. 2023;(88):147. doi: 10.36604/1998-5029-2023-88-147-158